<TEXT>&#2;<DATELINE>2007</DATELINE><TITLE>Turning biodefense dollars into products</TITLE><BODY>Five years after the US anthrax attacks, and more than two years after BioShield legislation was ratified, a survey reveals that biodefense funding has thus far produced only a handful of products for clinical development.&#3;</BODY></TEXT>